Stockscreener 앱 받기
13.61
3.50%
0.46
시간 외 거래:
13.58
-0.03
-0.22%
Moonlake Immunotherapeutics 주식(MLTX)의 최신 뉴스
MLTX Class Action Reminder – Robbins LLP Reminds MoonLake - GlobeNewswire
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, - GlobeNewswire
MoonLake Immunotherapeutics’ (MLTX) Reported Phase 3 Trial - GlobeNewswire
Investors in MoonLake Immunotherapeutics Should Contact The - GlobeNewswire
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of - GlobeNewswire
2025-11-24 | Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class Action | NDAQ:MLTX | Press Release - Stockhouse
MLTX Investors Have Opportunity to Lead MoonLake - GlobeNewswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2025-11-23 | Investors in MoonLake Immunotherapeutics (MLTX): Protect Your RightsContact Levi & Korsinsky Before December 15, 2025 | NDAQ:MLTX | Press Release - Stockhouse
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
MLTX INVESTOR REMINDER: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action Lawsuit - MarketScreener
MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15 - GlobeNewswire
HC Wainwright Lowers MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target to $26.00 - Defense World
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit - Morningstar
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class ActionMLTX - MarketScreener
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - PR Newswire
Moonlake Immunotherapeutics stock price target lowered to $26 at H.C. Wainwright - Investing.com India
HC Wainwright & Co. Maintains MoonLake Immunotherapeutics (MLTX) Buy Recommendation - Nasdaq
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Burned by MoonLake Immunotherapeutics? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join - GlobeNewswire
MLTX INVESTORS: BFA Law Reminds MoonLake Immunotherapeutics Investors with Losses to Contact the Firm Before the Imminent December 15 Securities Class Action Deadline - MarketScreener
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates - GlobeNewswire
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - FinancialContent
MLTX LAWSUIT ALERT: The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MarketScreener
MLTX LEGAL REMINDER: MoonLake Immunotherapeutics Faces Securities Allegations over Drug Trial Results -- Investors Alerted to Contact BFA Law before December 15 - ACCESS Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake - GlobeNewswire
MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) - GlobeNewswire
The Gross Law Firm Notifies MoonLake Immunotherapeutics - GlobeNewswire
MLTX LAWSUIT: MoonLake Immunotherapeutics Investors are Notified to Contact BFA Law about the Filed Securities Fraud Class Action and Important December 15 Deadline - Newsfile
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class Action - The Globe and Mail
Holdings of MoonLake Immunotherapeutics (MLTX) are aligned with the stars - Setenews
MLTX CLASS NOTICE: BFA Law Alerts MoonLake Immunotherapeutics Investors of the Pending Securities Fraud Class Action and Upcoming December 15 Deadline - Newsfile
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class ActionMLTX - MarketScreener
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action - GuruFocus
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman - PR Newswire
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out - Yahoo Finance
Precision Trading with Moonlake Immunotherapeutics (MLTX) Risk Zones - news.stocktradersdaily.com
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities ViolationsContact Levi & Korsinsky Today - Newsfile
MLTX DEADLINE REMINDER: MoonLake Immunotherapeutics 90% Stock Drop Triggers Securities Fraud Class ActionInvestors Urged to Contact BFA Law by December 15 - ACCESS Newswire
MLTX MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Securities Class Action LawsuitRGRD Law - MarketScreener
MLTX INVESTOR ALERT: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Securities Class Action LawsuitRGRD Law - GlobeNewswire
MLTX DEADLINE REMINDER: Berger Montague Reminds MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Important Class Action Lawsuit Deadline - Eastern Progress
MoonLake Immunotherapeutics Stock: Ignore The Panic, Catch The Upside (NASDAQ:MLTX) - Seeking Alpha
0.53%
1.88%
자본화:
|
볼륨(24시간):